1.
Armstrong A, Langley R, Gordon K, Warren R, Thaçi D, Stein Gold L, Peterson L, Madden C, Nunez Gomez N, de Cuyper D, Costanzo A. Bimekizumab infection rates in patients with moderate to severe plaque psoriasis: Analysis of pooled data from 2 years of treatment in phase 3 and 3b clinical trials. J of Skin [Internet]. 2022Nov.16 [cited 2024Mar.29];6(6):s72. Available from: https://jofskin.org/index.php/skin/article/view/1829